Delivery Order SPE2DB22D3011-SPE2DB24FP9TF
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide MYRBETRIQ ER 50 MG TABLET 90S. The contract, valued at $4,878.73, has an ultimate completion date of February 3, 2022. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of MYRBETRIQ ER 25 MG TABLET 90S. The contract has a potential value of $5,415.47 and a completion date of February 14, 2024. Amerisourcebergen Drug Corp is the prime contractor and has not received any set-aside designations for this award. This delivery order contract is part of a larger indefinite delivery...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide MYRBETRIQ ER 50 MG TABLET 90S. The award, valued at $31,007.01, has a completion date of February 7, 2024. AmerisourceBergen Drug Corp is the prime contractor and there are no set-aside designations on this award. The company holds an indefinite delivery contract (IDC) with DLA, valued up to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply 4564028065 - MYRBETRIQ ER 25 MG TABLET 90S. The $1,767.98 contract has a performance period through March 21, 2024 and does not have any set-aside designation. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) valued up to $999,999,999.00 awarded by DLA with a performance...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide MYRBETRIQ ER 25 MG TABLET 30S. The contract has a potential value of $1,278.57 and a completion date of February 22, 2024. This delivery order is part of an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA, which serves as the primary vehicle for the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide the pharmaceutical product MYRBETRIQ ER 25 MG TABLET 30S. The award, valued at $12,556.25, has an ultimate completion date of April 9, 2024. AmerisourceBergen Drug Corp is the prime contractor on an Indefinite Delivery Contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of MYRBETRIQ ER 25 MG TABLET 90S. The contract has a potential value of $5,401.32 and a completion date of March 8, 2024. Amerisourcebergen Drug Corp is the prime contractor, and there are no set-aside designations indicated for this award. In addition to this delivery order, Amerisourcebergen Drug...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4564073658 MYRBETRIQ ER 25 MG TABLET 30S. The contract has a ceiling value of $1,581.55 and a performance period through March 26, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a period...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,184,275 units of the pharmaceutical product MYRBETRIQ ER 50 MG TABLET 90S. The $28,014.79 delivery order was issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp as the prime contractor, which has a potential value of $999,999,999.00 and a performance period through...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,841.66 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of MYRBETRIQ ER 25 MG TABLET 30S, a pharmaceutical product, and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is a part of a larger indefinite delivery...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB24FP9TFDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of MYRBETRIQ ER 50 MG tablets. The $5,448.95 contract has a completion date of March 12, 2024 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This delivery order was issued under that IDC. AmerisourceBergen Corporation is the parent company of the prime contractor.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 3/11/24 |